Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

International Paper (IP) : "This stock is too cheap and I like it."

Inogen (INGN) : "I like medical devices and this is a fast growing company."

Teva Pharmaceuticals (TEVA) : "No, you don't want to touch Teva."

On Real Money, Cramer says a great defensive play is easier than you think. Get his insights with a free trial subscription to Real Money.

Cramer and the AAP team say that after TJX's (TJX) strong quarter, they are encouraged by the outlook and management's approach to customer loyalty. Find out what they're telling their investment club members now and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in TJX.

More from Jim Cramer

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Jim Cramer: Here's the State of Play as We Head Into Next Week's Action

Jim Cramer: Here's the State of Play as We Head Into Next Week's Action

Jim Cramer: I Can't Tell You to Buy This Market

Jim Cramer: I Can't Tell You to Buy This Market